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For nearly 10 years, therapeutic mild hypothermia has be-
come increasingly recognized to positively inﬂuence neuro-
logical outcome in humans following acute brain injuries,
namely,ischemicbraininjuryduetocardiacarrestandhypo-
xic-ischemic encephalopathy in neonates. In the laboratory,
hypothermia is perhaps the most robust and consistent neu-
roprotectant studied to date. It has been shown to both sup-
press and enhance many factors leading to ultimate tissue
preservationandbetteroutcome.Nowthatithasbeenshown
to be eﬀective in humans, this special issue surveys the var-
ious directions this area of research is taking, from using it
as a model of neuroprotection in the laboratory to reﬁning
the technique and exploring ways of applying hypothermia
to other neurological conditions, especially stroke.
Y.Shintanietal.provideanoverviewofhowstate-of-the-
art molecular gene and protein proﬁling technologies can be
applied to models of hypothermic neuroprotection to reveal
potentially new signaling pathways and to identify potential
therapeutic targets. This strategy was then demonstrated by
H.S.Hanetal.whodiscoveredthathypothermiaupregulates
extracellular signal regulated kinase (ERK-1/2) and that
ERK-1/2 upregulation might be responsible for the anti-in-
ﬂammatory properties of cooling.
Therapeutic hypothermia has become increasingly em-
braced by the medical community as a means of improving
neurological outcome in certain conditions. However, this
intervention still has its limitations. Since these trials were
published, centers have struggled to determine optimal
cooling techniques, such as surface cooling versus endovas-
cular methods. A. F. Caulﬁeld et al. report their experience
with both approaches at an academic stroke center. Another
critical question is whether therapeutic cooling can be of-
fered in community settings or whether patients need to
be referred to tertiary centers. The study by M. P. Shah and
colleagues show that it is possible to implement a cooling
protocol in a community hospital, provided that there is a
team approach in place, involving relevant medical services.
Encouraging clinical studies in cardiac arrest and hyp-
oxic-ischemic encephalopathy patients has fueled further
interest in pursuing therapeutic cooling in stroke victims.
However, stroke poses additional challenges since most
stroke victims are elderly with many comorbidities. Stroke
patients are also generally awake, making cooling more diﬃ-
cultduetotheproblemofshivering.Nevertheless,preclinical
studies continue to reﬁne optimal parameters for such an
intervention in stroke models, including deﬁning the lim-
its of hypothermic protection, whether cooling might be
combined with other therapies and understanding where
preclinical models might fall short of the clinical condition.
These issues are explored in reviews by H. G. Zhao and
Steinberg and Zgavc et al. Still, there is an urgent need for
larger,prospective studies to determine if hypothermia could
be used in stroke patients. Bench scientists, translational
researchers, and clinicians alike must work together towards
this goal.
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